[BolliBatlu]

Covid-19: Rs 56-cr 'CAWACH' at IIT-B to scout for 50 innovations
Science ministry sets up a rapid response centre at IIT Bombay to combat COVID-19

C-CAMP nominates top 5 COVID-19 innovations

Awareness of Covid-19 higher in India's Tier-1 cities, says study by IITs
IITs study COVID-19 impact on daily commuters

Indian researchers make coating to kill virus like COVID

Covid-19: Indian biotech fights back

TCS and CSIR accomplice to plan AI based medication for COVID-19

National Innovation Foundation – India invite innovative citizens to participate in Challenge COVID-19 Competition (C3)
NIF Covid-19 challenge seeks innovative solutions to mitigate pandemic impact

COVID-19: Research community counters misinformation with “CovidGyan”

Ramdev’s Patanjali submits a herbs+hydroxychloroquine plan to treat Covid-19

Patanjali Ayurveda has also submitted a research paper to a medical journal claiming ashwagandha herb stops entry of coronavirus into human body.

New Delhi: Ramdev’s Patanjali Ayurveda has submitted a proposal to the Modi government for the “treatment and prevention” of Covid-19 using medicinal herbs along with allopathic medicine hydroxychloroquine, which is an anti-malarial drug.

The proposal, prepared by Haridwar-based Patanjali Research Institute (PRI) that functions under the Patanjali Ayurveda, stated that phytochemicals in ashwagandha, giloy and tulsi have the potential to fight Covid-19.

“Like China has used the combination of traditional medicine and modern medicine, we have submitted a treatment protocol (to the government) using ayurveda, which can be used along with ICMR-prescribed allopathic treatment for treating Covid-19 patients,” Balkrishna added.

IIT Dharwad makes 500 3D-printed face shields for medical staff fighting COVID-19
Hubballi: City-based startup develops two devices to fight Covid-19
Covid-19: IIT Kanpur to manufacture cost efficient antiviral coating masks
COVID-19: IIT-H suggests cheaper alternative to ventilators

COVID-19: Bharat Biotech Developing Intranasal Vaccine Against Coronavirus

IIT Delhi Allocates Supercomputer Resources For COVID-19 Research To Merit-Based Proposals
IIT-Delhi invites proposals for COVID-19 research

‘Look into Covid- related innovations’: Telangana Minister for IT and Industries KT Rama Rao

COVID-19: What Are Serological Tests, and How Can They Help India
India Needs to Establish an Infectious Disease Forecast Centre Urgently
Avalon's CEO reflects on the way forward for Covid-19 response

Tracking COVID-19 in India: The BCG Hypothesis

Indians do not have genetic protection against coronavirus, published research incorrectly interpreted

ICMR allows rapid testing for COVID-19, issues guidelines
How rapid antibody tests are different from existing PCR tests for Covid-19 | Explained

In fight against coronavirus, India’s universities have lagged far behind China’s
What Covid-19 can teach us about redefining our academics and research

Startup Street: Top VCs Have Tips For Entrepreneurs During Covid-19 Crisis

Coronavirus: Biotech startup AmpliGene India's COVID-19 testing kit could be the fastest in the world
Molbio Diagnostics' testing kit for COVID-19 approved by ICMR

Government funded start-up working on rapid test kit

DST funds Pune healthcare startup for rapid detection of COVID-19

COVID-19 outbreak: DRDO develops disinfection chamber, face mask
Indian Railways Jagadhari Workshop makes coverall PPEs approved by DRDO; builds Fumigation Tunnel – details

India-Australia Ready To Share COVID-19 Research Efforts

View: Faith in Indian science and technology begins at home

SIDBI comes out in support of startups during COVID-19 by launching financial assistance

COVID-19: A hackathon through virtual mode brings in new ideas

Here's How India's Science, Technology Institutions Working Against COVID-19


Research & Innovations Issues

Startup Policy Rundown: Startups Demand Financial Aid To Survive Covid-19 Fallout

How red tape, government delays have left biotech start-ups struggling to ramp up their war against COVID-19

Summa: Permits, premier research labs closed, access to reliable information, absence of staff due to curfew, supply are a few of issues faced by startups


Research & Innovations Best Practices

Indian startups at forefront during COVID-19 crisis